Zobrazeno 101 - 110
of 244
pro vyhledávání: '"Kari Kuulasmaa"'
Autor:
Maria Hughes, Renate B. Schnabel, Francisco Ojeda, Allan D. Struthers, Veikko Salomaa, Hugh Tunstall-Pedoe, Mark Woodward, Stefan Blankenberg, Olli Saarela, Kari Kuulasmaa, Frank Kee, Tanja Zeller, Tarja Tuovinen
Publikováno v:
European Heart Journal; Vol 35
Aims Our aim was to test the prediction and clinical applicability of high-sensitivity assayed troponin I for incident cardiovascular events in a general middle-aged European population. Methods and results High-sensitivity assayed troponin I was mea
Autor:
John M, Gregson, Daniel F, Freitag, Praveen, Surendran, Nathan O, Stitziel, Rajiv, Chowdhury, Stephen, Burgess, Stephen, Kaptoge, Pei, Gao, James R, Staley, Peter, Willeit, Sune F, Nielsen, Muriel, Caslake, Stella, Trompet, Linda M, Polfus, Kari, Kuulasmaa, Jukka, Kontto, Markus, Perola, Stefan, Blankenberg, Giovanni, Veronesi, Francesco, Gianfagna, Satu, Männistö, Akinori, Kimura, Honghuang, Lin, Dermot F, Reilly, Mathias, Gorski, Vladan, Mijatovic, Patricia B, Munroe, Georg B, Ehret, Alex, Thompson, Maria, Uria-Nickelsen, Anders, Malarstig, Abbas, Dehghan, Thomas F, Vogt, Taishi, Sasaoka, Fumihiko, Takeuchi, Norihiro, Kato, Yoshiji, Yamada, Frank, Kee, Martina, Müller-Nurasyid, Jean, Ferrières, Dominique, Arveiler, Philippe, Amouyel, Veikko, Salomaa, Eric, Boerwinkle, Simon G, Thompson, Ian, Ford, J, Wouter Jukema, Naveed, Sattar, Chris J, Packard, Abdulla Al, Shafi Majumder, Dewan S, Alam, Panos, Deloukas, Heribert, Schunkert, Nilesh J, Samani, Sekar, Kathiresan, Børge G, Nordestgaard, Danish, Saleheen, Joanna Mm, Howson, Emanuele, Di Angelantonio, Adam S, Butterworth, John, Danesh
Publikováno v:
European journal of preventive cardiology. 24(5)
Aims Darapladib, a potent inhibitor of lipoprotein-associated phospholipase A
Health examination survey measurements can be standardized – experiences from the EHES Pilot Project
Publikováno v:
European Journal of Public Health. 26
Autor:
Dewan S. Alam, Martina Müller-Nurasyid, Pei Gao, Akinori Kimura, Danish Saleheen, Emanuele Di Angelantonio, Stefan Blankenberg, Taishi Sasaoka, Jean Ferrières, Børge G. Nordestgaard, Panos Deloukas, Abbas Dehghan, Eric Boerwinkle, Maria Uria-Nickelsen, Simon G. Thompson, Markus Perola, Chris J. Packard, Giovanni Veronesi, Dominique Arveiler, Dermot F. Reilly, Patricia B. Munroe, Stephen Burgess, Rajiv Chowdhury, Philippe Amouyel, J. Wouter Jukema, Alex Thompson, Francesco Gianfagna, Satu Männistö, Honghuang Lin, Nathan O. Stitziel, Heribert Schunkert, Naveed Sattar, Vladan Mijatovic, Abdulla Al Shafi Majumder, Nilesh J. Samani, Daniel F. Freitag, Stephen Kaptoge, Sekar Kathiresan, Stella Trompet, Peter Willeit, Jukka Kontto, John Danesh, Georg Ehret, Veikko Salomaa, Adam S. Butterworth, Joanna M. M. Howson, Ian Ford, Mathias Gorski, Kari Kuulasmaa, Yoshiji Yamada, Norihiro Kato, John M. Gregson, Frank Kee, Fumihiko Takeuchi, Praveen Surendran, James R Staley, Linda M. Polfus, Sune F. Nielsen, Anders Mälarstig, Thomas F. Vogt, Muriel J. Caslake
Publikováno v:
European Journal of Preventive Cardiology, 24(5), 492-504
Gregson, J M, Freitag, D F, Surendran, P, Stitziel, N O, Chowdhury, R, Burgess, S, Kaptoge, S, Gao, P, Staley, J R, Willeit, P, Nielsen, S F, Caslake, M, Trompet, S, Polfus, L M, Kuulasmaa, K, Kontto, J, Perola, M, Blankenberg, S, Veronesi, G, Gianfagna, F, Männistö, S, Kimura, A, Lin, H, Reilly, D F, Gorski, M, Mijatovic, V, Munroe, P B, Ehret, G B, Thompson, A, Uria-Nickelsen, M, Malarstig, A, Dehghan, A, Vogt, T F, Sasaoka, T, Takeuchi, F, Kato, N, Yamada, Y, Kee, F, Müller-Nurasyid, M, Ferrières, J, Arveiler, D, Amouyel, P, Salomaa, V, Boerwinkle, E, Thompson, S G, Ford, I, Wouter Jukema, J, Sattar, N, Packard, C J, Shafi Majumder, A A, Alam, D S, Deloukas, P, Schunkert, H, Samani, N J, Kathiresan, S, Nordestgaard, B G, Saleheen, D, Howson, J M, Di Angelantonio, E, Butterworth, A S & Danesh, J 2017, ' Genetic invalidation of Lp-PLA 2 as a therapeutic target : Large-scale study of five functional Lp-PLA 2-lowering alleles ', European Journal of Preventive Cardiology, vol. 24, no. 5, pp. 492-504 . https://doi.org/10.1177/2047487316682186
European journal of preventive cardiology, vol. 24, no. 5, pp. 492-504
European Journal of Preventive Cardiology, 24(5), 492-504. SAGE Publications Ltd
Gregson, J M, Freitag, D F, Surendran, P, Stitziel, N O, Chowdhury, R, Burgess, S, Stephen, K, Gao, P, Staley, J R, Willeit, P, Nielsen, S F, Caslake, M, Trompet, S, Polfus, L M, Kuulasmaa, K, Kontto, J, Perola, M, Blankenberg, S, Veronesi, G, Gianfagna, F, Mannisto, S, Kimura, A, Lin, H, Reilly, D F, Gorski, M, Mijatovic, V, CKDGen consortium, Munroe, P B, Ehret, G B, International Consortium for Blood Pressure, Thompson, A, Uria-Nickelsen, M, Malarstig, A, Dehghan, A, CHARGE inflammation working group, Vogt, T F, Sasaoka, T, Takeuchi, F, Kato, N, Yamada, Y, Kee, F, Muller-Nurasyid, M, Ferrieres, J, Arveiler, D, Amouyel, P, Salomaa, V, Boerwinkle, E, Thompson, S G, Ford, I, Jukema, J W, Sattar, N, Packard, C J, Majumder, A A S, Alam, D S, Deloukas, P, Schunkert, H, Samani, N J, Kathiresan, S, MICAD Exome consortium, Nordestgaard, B G, Saleheen, D, Howson, J M M, Di Angelantonio, E, Butterworth, A S, Danesh, J, EPIC-CVD consortium & CHD Exome+ consortium 2017, ' Genetic invalidation of Lp-PLA2 as a therapeutic target: Large-scale study of five functional Lp-PLA2-lowering alleles ', European Journal of Preventive Cardiology, vol. 24, no. 5, pp. 492-504 . https://doi.org/10.1177/2047487316682186
Gregson, J M, Freitag, D F, Surendran, P, Stitziel, N O, Chowdhury, R, Burgess, S, Kaptoge, S, Gao, P, Staley, J R, Willeit, P, Nielsen, S F, Caslake, M, Trompet, S, Polfus, L M, Kuulasmaa, K, Kontto, J, Perola, M, Blankenberg, S, Veronesi, G, Gianfagna, F, Männistö, S, Kimura, A, Lin, H, Reilly, D F, Gorski, M, Mijatovic, V, Munroe, P B, Ehret, G B, Thompson, A, Uria-Nickelsen, M, Malarstig, A, Dehghan, A, Vogt, T F, Sasaoka, T, Takeuchi, F, Kato, N, Yamada, Y, Kee, F, Müller-Nurasyid, M, Ferrières, J, Arveiler, D, Amouyel, P, Salomaa, V, Boerwinkle, E, Thompson, S G, Ford, I, Wouter Jukema, J, Sattar, N, Packard, C J, Shafi Majumder, A A, Alam, D S, Deloukas, P, Schunkert, H, Samani, N J, Kathiresan, S, Nordestgaard, B G, Saleheen, D, Howson, J M, Di Angelantonio, E, Butterworth, A S & Danesh, J 2017, ' Genetic invalidation of Lp-PLA 2 as a therapeutic target : Large-scale study of five functional Lp-PLA 2-lowering alleles ', European Journal of Preventive Cardiology, vol. 24, no. 5, pp. 492-504 . https://doi.org/10.1177/2047487316682186
European journal of preventive cardiology, vol. 24, no. 5, pp. 492-504
European Journal of Preventive Cardiology, 24(5), 492-504. SAGE Publications Ltd
Gregson, J M, Freitag, D F, Surendran, P, Stitziel, N O, Chowdhury, R, Burgess, S, Stephen, K, Gao, P, Staley, J R, Willeit, P, Nielsen, S F, Caslake, M, Trompet, S, Polfus, L M, Kuulasmaa, K, Kontto, J, Perola, M, Blankenberg, S, Veronesi, G, Gianfagna, F, Mannisto, S, Kimura, A, Lin, H, Reilly, D F, Gorski, M, Mijatovic, V, CKDGen consortium, Munroe, P B, Ehret, G B, International Consortium for Blood Pressure, Thompson, A, Uria-Nickelsen, M, Malarstig, A, Dehghan, A, CHARGE inflammation working group, Vogt, T F, Sasaoka, T, Takeuchi, F, Kato, N, Yamada, Y, Kee, F, Muller-Nurasyid, M, Ferrieres, J, Arveiler, D, Amouyel, P, Salomaa, V, Boerwinkle, E, Thompson, S G, Ford, I, Jukema, J W, Sattar, N, Packard, C J, Majumder, A A S, Alam, D S, Deloukas, P, Schunkert, H, Samani, N J, Kathiresan, S, MICAD Exome consortium, Nordestgaard, B G, Saleheen, D, Howson, J M M, Di Angelantonio, E, Butterworth, A S, Danesh, J, EPIC-CVD consortium & CHD Exome+ consortium 2017, ' Genetic invalidation of Lp-PLA2 as a therapeutic target: Large-scale study of five functional Lp-PLA2-lowering alleles ', European Journal of Preventive Cardiology, vol. 24, no. 5, pp. 492-504 . https://doi.org/10.1177/2047487316682186
Aims Darapladib, a potent inhibitor of lipoprotein-associated phospholipase A javax.xml.bind.JAXBElement@3ed2b341 (Lp-PLA javax.xml.bind.JAXBElement@3d94c871 ), has not reduced risk of cardiovascular disease outcomes in recent randomized trials. We a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46b2ff2015d30a1017632842598090d2
http://hdl.handle.net/10044/1/54554
http://hdl.handle.net/10044/1/54554
Autor:
Julie K K, Vishram, Anders, Borglykke, Anne H, Andreasen, Jørgen, Jeppesen, Hans, Ibsen, Torben, Jørgensen, Grazyna, Broda, Luigi, Palmieri, Simona, Giampaoli, Chiara, Donfrancesco, Frank, Kee, Giuseppe, Mancia, Giancarlo, Cesana, Kari, Kuulasmaa, Susana, Sans, Michael H, Olsen, B, Stegmayr
Publikováno v:
Hypertension
Vishram, J K K, Borglykke, A R, Andreasen, A H, Jeppesen, J, Ibsen, H, Jørgensen, T, Broda, G, Palmieri, L, Giampaoli, S, Donfrancesco, C, Kee, F, Mancia, G, Cesana, G, Kuulasmaa, K, Sans, S, Olsen, M H & MORGAM Project 2012, ' Impact of age on the importance of systolic and diastolic blood pressures for stroke risk : the MOnica, Risk, Genetics, Archiving, and Monograph (MORGAM) Project ', Hypertension, vol. 60, no. 5, pp. 1117-23 . https://doi.org/10.1161/HYPERTENSIONAHA.112.201400
Hypertension; Vol 60
Vishram, J K K, Borglykke, A R, Andreasen, A H, Jeppesen, J, Ibsen, H, Jørgensen, T, Broda, G, Palmieri, L, Giampaoli, S, Donfrancesco, C, Kee, F, Mancia, G, Cesana, G, Kuulasmaa, K, Sans, S, Olsen, M H & MORGAM Project 2012, ' Impact of age on the importance of systolic and diastolic blood pressures for stroke risk : the MOnica, Risk, Genetics, Archiving, and Monograph (MORGAM) Project ', Hypertension, vol. 60, no. 5, pp. 1117-23 . https://doi.org/10.1161/HYPERTENSIONAHA.112.201400
Hypertension; Vol 60
This study investigates age-related shifts in the relative importance of systolic (SBP) and diastolic (DBP) blood pressures as predictors of stroke and whether these relations are influenced by other cardiovascular risk factors. Using 34 European coh
Autor:
Hanna Tolonen, Kari Kuulasmaa
Publikováno v:
Global Heart; Vol 11, No 2 (2016); 217-221
Europe PubMed Central
Europe PubMed Central
The World Health Organization's MONICA (Multinational Monitoring of Trends and Determinants in Cardiovascular Disease) Project was established after the increase in mortality from coronary heart disease had turned to a decline in some countries. Its
Autor:
Danish, Saleheen, Wei, Zhao, Robin, Young, Christopher P, Nelson, WeangKee, Ho, Jane F, Ferguson, Asif, Rasheed, Kristy, Ou, Sylvia T, Nurnberg, Robert C, Bauer, Anuj, Goel, Ron, Do, Alexandre F R, Stewart, Jaana, Hartiala, Weihua, Zhang, Gudmar, Thorleifsson, Rona J, Strawbridge, Juha, Sinisalo, Stavroula, Kanoni, Sanaz, Sedaghat, Eirini, Marouli, Kati, Kristiansson, Jing, Hua Zhao, Robert, Scott, Dominique, Gauguier, Svati H, Shah, Albert Vernon, Smith, Natalie, van Zuydam, Amanda J, Cox, Christina, Willenborg, Thorsten, Kessler, Lingyao, Zeng, Michael A, Province, Andrea, Ganna, Lars, Lind, Nancy L, Pedersen, Charles C, White, Anni, Joensuu, Marcus, Edi Kleber, Alistair S, Hall, Winfried, März, Veikko, Salomaa, Christopher, O'Donnell, Erik, Ingelsson, Mary F, Feitosa, Jeanette, Erdmann, Donald W, Bowden, Colin N A, Palmer, Vilmundur, Gudnason, Ulf De, Faire, Pierre, Zalloua, Nicholas, Wareham, John R, Thompson, Kari, Kuulasmaa, George, Dedoussis, Markus, Perola, Abbas, Dehghan, John C, Chambers, Jaspal, Kooner, Hooman, Allayee, Panos, Deloukas, Ruth, McPherson, Kari, Stefansson, Heribert, Schunkert, Sekar, Kathiresan, Martin, Farrall, Philippe, Marcel Frossard, Daniel J, Rader, Nilesh J, Samani, Muredach P, Reilly
Publikováno v:
Circulation. 135(24)
Common diseases such as coronary heart disease (CHD) are complex in etiology. The interaction of genetic susceptibility with lifestyle factors may play a prominent role. However, gene-lifestyle interactions for CHD have been difficult to identify. He
Autor:
Niclas Håkansson, Ute Mons, José M Ordóñez-Mena, Rikje Ruiter, Albert Hofman, Stefan Söderberg, Mark G. O'Doherty, Angela Scott, Heinz Freisling, Frank Kee, Catherine E. de Keyser, Paolo Boffetta, Abdonas Tamosiunas, Tom Wilsgaard, Lena Maria Nilsson, Andrzej Pająk, Kari Kuulasmaa, Antonia Trichopoulou, Martin Bobak, Sofia Malyutina, Ellen Kampman, Bruno H. Stricker, Philippos Orfanos, Mazda Jenab, Růžena Kubínová, Pekka Jousilahti, Lisette C. P. G. M. de Groot, Alicja Wolk, Neal D. Freedman, Nicola Orsini, Bas Bueno-de-Mesquita, Ben Schöttker, Michail Katsoulis, Anne Tjønneland, Hermann Brenner
Publikováno v:
BMC Medicine
BMC Medicine, 14, 62
Ordóñez-Mena, J M, Schöttker, B, Mons, U, Jenab, M, Freisling, H, Bueno-de-Mesquita, B, O'Doherty, M G, Scott, A, Kee, F, Stricker, B H, Hofman, A, de Keyser, C E, Ruiter, R, Söderberg, S, Jousilahti, P, Kuulasmaa, K, Freedman, N D, Wilsgaard, T, de Groot, L C, Kampman, E, Håkansson, N, Orsini, N, Wolk, A, Nilsson, L M, Tjønneland, A, Pająk, A, Malyutina, S, Kubínová, R, Tamosiunas, A, Bobak, M, Katsoulis, M, Orfanos, P, Boffetta, P, Trichopoulou, A, Brenner, H & Consortium on Health and Ageing: Network of Cohorts in Europe and the United States (CHANCES) 2016, ' Quantification of the smoking-associated cancer risk with rate advancement periods: meta-analysis of individual participant data from cohorts of the CHANCES consortium ', BMC Medicine, vol. 14, 62 . https://doi.org/10.1186/s12916-016-0607-5
BMC Medicine, 14, pp. 62
BMC Medicine 14 (2016) 1
BMC Medicine, 14:62. BioMed Central Ltd.
BMC Medicine, 14(1)
BMC Medicine, 14, 62
Ordóñez-Mena, J M, Schöttker, B, Mons, U, Jenab, M, Freisling, H, Bueno-de-Mesquita, B, O'Doherty, M G, Scott, A, Kee, F, Stricker, B H, Hofman, A, de Keyser, C E, Ruiter, R, Söderberg, S, Jousilahti, P, Kuulasmaa, K, Freedman, N D, Wilsgaard, T, de Groot, L C, Kampman, E, Håkansson, N, Orsini, N, Wolk, A, Nilsson, L M, Tjønneland, A, Pająk, A, Malyutina, S, Kubínová, R, Tamosiunas, A, Bobak, M, Katsoulis, M, Orfanos, P, Boffetta, P, Trichopoulou, A, Brenner, H & Consortium on Health and Ageing: Network of Cohorts in Europe and the United States (CHANCES) 2016, ' Quantification of the smoking-associated cancer risk with rate advancement periods: meta-analysis of individual participant data from cohorts of the CHANCES consortium ', BMC Medicine, vol. 14, 62 . https://doi.org/10.1186/s12916-016-0607-5
BMC Medicine, 14, pp. 62
BMC Medicine 14 (2016) 1
BMC Medicine, 14:62. BioMed Central Ltd.
BMC Medicine, 14(1)
Source: doi: 10.1186/s12916-016-0607-5 Background: Smoking is the most important individual risk factor for many cancer sites but its association with breast and prostate cancer is not entirely clear. Rate advancement periods (RAPs) may enhance commu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::632414458bb97989f94459e464c142a5
https://hdl.handle.net/10037/10368
https://hdl.handle.net/10037/10368
Autor:
Giancarlo Cesana, Sofia Malyutina, Veikko Salomaa, Giovanni Veronesi, Torben Jørgensen, Annette Peters, Philippe Amouyel, Wojciech Drygas, Frank Kee, Stefan Söderberg, Andrzej Pajak, Abdonas Tamosiunas, Jean Ferrières, Dominique Arveiler, Marco M Ferrario, Kari Kuulasmaa, Simona Giampaoli, Martin Bobak, Lloyd E. Chambless, Hugh Tunstall-Pedoe
Publikováno v:
Stroke. 47
Introduction and aim: There are limited comparative data on social inequalities in stroke morbidity across Europe. We aimed to assess the magnitude of educational class inequalities in stroke mortality, incidence and 1-year case-fatality in European
Publikováno v:
Global Heart; Vol 11, No 2 (2016); 201-205
During the last 40 years, Finland has experienced a remarkable decline in coronary heart disease and stroke mortality. The latest coronary heart disease mortality figures in the working-age population are 80% in Finland.Stroke mortality in persons ag